← Leaderboards
Ziying Yan
University Of Kansas Medical Center
$1,506,776
Attributed
$3,013,551
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $889K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,013,551 · 5
By mechanism
R21$1,747,739 · 4
R01$1,265,812 · 1
Top collaborators
- Jianming Qiu10 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Jianming Qiu$11,839,179
- Mohammad A.k. Rumi$2,019,803
- Christopher J Thorpe$329,620
- Soumen Paul$14,577,427
- Deepika Polineni$689,065
Others in their field
Other Emerging Leaders on “Genome”
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- Scott Topper · Broad Institute, Inc.$153,234,573
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
- Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Scott Andrew Sutherland · Vignet, Inc.$37,105,117
Research focus
GenomeRecombinant Adeno-Associated Virus (Raav)VectorAirway EpitheliumTropismCystic FibrosisIn VitroAdeno-Associated Viral VectorCapsidGene TherapySuccessClinical TrialsLungRegulator GenesLibrariesMediatingDirected Molecular EvolutionInfectionGenesIn VivoLiquid SubstanceFerretsApicalPulmonary Cystic Fibrosis
Grant awards (10)
Development of novel approaches for gene editing therapies of cystic fibrosis$623,412
R01 · FY2025 · HL
Development of myotropic human bocavirus vectors for gene therapy$194,075
R21 · FY2025 · AI
Development of novel approaches for gene editing therapies of cystic fibrosis$642,400
R01 · FY2024 · HL
Development of myotropic human bocavirus vectors for gene therapy$246,600
R21 · FY2024 · AI
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways$193,438
R21 · FY2022 · AI
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways$244,800
R21 · FY2021 · AI
Mechanisms Underlying the Transduction Polarity of AAV in Polarized Human Airway Epithelium$191,925
R21 · FY2021 · AI
Mechanisms Underlying the Transduction Polarity of AAV in Polarized Human Airway Epithelium$243,313
R21 · FY2020 · AI
Human bocavirus 1 (HBoV1) capsid entry and intracellular trafficking of polarized human airway epithelium$191,025
R21 · FY2019 · AI
Human bocavirus 1 (HBoV1) capsid entry and intracellular trafficking of polarized human airway epithelium$242,563
R21 · FY2018 · AI